{"transactions":[{"id":3435066,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-19T23:07:55.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":3819,"price":18.15,"value":69314.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.87 to $18.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":162759,"source":{"system":"sec-edgar","filing":"0001209191-19-046718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119046718/doc4.xml","form_type":"4"}},{"id":3522246,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-18T00:21:18.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":4077,"price":31.37,"value":127895.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":166578,"source":{"system":"sec-edgar","filing":"0001209191-19-031188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119031188/doc4.xml","form_type":"4"}},{"id":3643124,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-22T01:15:40.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":3822,"price":42.39,"value":162014.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":170655,"source":{"system":"sec-edgar","filing":"0001209191-19-012335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119012335/doc4.xml","form_type":"4"}},{"id":3682931,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2019-01-30T23:02:58.000Z","date":"2019-01-28","kind":"exercise","acquired":false,"shares":63000,"price":10.69,"value":673470.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":10.69,"exercise_date":"2015-02-08","expiration_date":"2019-02-07","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001209191-19-006044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/doc4.xml","form_type":"4"}},{"id":3682930,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-30T23:02:58.000Z","date":"2019-01-28","kind":"sale","acquired":false,"shares":63000,"price":42.82,"value":2697660.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $42.31 to $43.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":174477,"source":{"system":"sec-edgar","filing":"0001209191-19-006044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/doc4.xml","form_type":"4"}},{"id":3682929,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-01-30T23:02:58.000Z","date":"2019-01-28","kind":"exercise","acquired":true,"shares":63000,"price":10.69,"value":673470.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Nicholson for certain options expiring on February 7, 2019."}],"balance_after":237477,"source":{"system":"sec-edgar","filing":"0001209191-19-006044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119006044/doc4.xml","form_type":"4"}},{"id":3759846,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-11-19T23:14:11.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":5982,"price":38.25,"value":228811.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.47 to $38.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":174477,"source":{"system":"sec-edgar","filing":"0001209191-18-059293","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118059293/doc4.xml","form_type":"4"}},{"id":3842489,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2018-08-17T01:46:25.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"These options, at the time of their grant were subject to both performance-based and time-based vesting requirements.   On August 15, 2018, the performance-based condition vesting was satisfied.  The time-based vesting is on a monthly pro-rata basis over a period of four years from the grant date (December 15, 2017)."},{"field":"date","element":"transactionDate","label":"F5","text":"These stock options were granted on December 15, 2017 and the performance-based vesting requirement for these stock options was satisfied on August 15, 2018 upon the Compensation Committee's certification of the successful acceptance of the New Drug Application by the FDA for NKTR-181."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option vests on a monthly pro-rata basis over a period of four years from the grant date."}],"balance_after":65000,"derivative":{"exercise_price":56.9,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-18-047242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047242/doc4.xml","form_type":"4"}},{"id":3842488,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-08-17T01:46:25.000Z","date":"2018-08-16","kind":"disposition_to_issuer","acquired":false,"shares":8137,"price":58.4,"value":475200.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $56.37 to $59.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":180459,"source":{"system":"sec-edgar","filing":"0001209191-18-047242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047242/doc4.xml","form_type":"4"}},{"id":3842487,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-08-17T01:46:25.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on December 15, 2017, were subject to both performance-based and time-based vesting requirements.  On August 15, 2018, the performance-based condition vesting was satisfied. The time-based vesting is on a quarterly pro-rata basis over a period of three (3) years from the date of grant."}],"balance_after":188596,"source":{"system":"sec-edgar","filing":"0001209191-18-047242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047242/doc4.xml","form_type":"4"}},{"id":3926602,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-05-18T23:05:06.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":4917,"price":83.39,"value":410028.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $81.35 to $84.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":162596,"source":{"system":"sec-edgar","filing":"0001209191-18-031596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118031596/doc4.xml","form_type":"4"}},{"id":4006584,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-08T23:09:31.000Z","date":"2018-03-07","kind":"sale","acquired":false,"shares":100144,"price":100.45,"value":10059464.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $99.00 to $101.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":167513,"source":{"system":"sec-edgar","filing":"0001209191-18-018221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118018221/doc4.xml","form_type":"4"}},{"id":4006583,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-08T23:09:31.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":120000,"price":98.29,"value":11794800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $98.00  to $100.04.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":267657,"source":{"system":"sec-edgar","filing":"0001209191-18-018221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118018221/doc4.xml","form_type":"4"}},{"id":4049277,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-21T00:09:11.000Z","date":"2018-02-16","kind":"sale","acquired":false,"shares":4879,"price":82.94,"value":404664.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $81.57 to $84.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":387657,"source":{"system":"sec-edgar","filing":"0001209191-18-011595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118011595/doc4.xml","form_type":"4"}},{"id":4080177,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2018-02-02T23:03:49.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made for stock options scheduled to expire on February 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":11.34,"exercise_date":"2014-02-01","expiration_date":"2018-02-01","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-18-007139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118007139/doc4.xml","form_type":"4"}},{"id":4080176,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-02T23:03:49.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":120000,"price":11.34,"value":1360800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made for stock options scheduled to expire on February 1, 2018."}],"balance_after":392536,"source":{"system":"sec-edgar","filing":"0001209191-18-007139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118007139/doc4.xml","form_type":"4"}},{"id":4127303,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2017-12-19T23:28:08.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":65000,"derivative":{"exercise_price":56.9,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-17-066481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117066481/doc4.xml","form_type":"4"}},{"id":4127302,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-12-19T23:28:08.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.  These RSUs vest over three years in substantially equal quarterly installments based on continued service."}],"balance_after":272536,"source":{"system":"sec-edgar","filing":"0001209191-17-066481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117066481/doc4.xml","form_type":"4"}},{"id":4158978,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2017-11-17T23:05:40.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"These options, at the time of their grant were subject to both performance-based and time-based vesting requirements.   On November 15, 2017, the performance-based condition vesting was satisfied.  The time-based vesting is on a monthly pro-rata basis over a period of four years from the grant date (December 13, 2016)."},{"field":"date","element":"transactionDate","label":"F6","text":"These stock options were granted on December 13, 2016 and the performance-based vesting requirement for these stock options was satisfied on November 15, 2017 upon the Compensation Committee's certification of the successful acceptance of the New Drug Application by the FDA for Ciprofloxacin Dry Powder Inhalation (Cipro CPI)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option vests on a monthly pro-rata basis over a period of four years from the grant date."}],"balance_after":50000,"derivative":{"exercise_price":14.41,"expiration_date":"2024-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-061594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117061594/doc4.xml","form_type":"4"}},{"id":4158977,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-17T23:05:40.000Z","date":"2017-11-16","kind":"disposition_to_issuer","acquired":false,"shares":6620,"price":44.23,"value":292802.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $41.98 to $45.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":246536,"source":{"system":"sec-edgar","filing":"0001209191-17-061594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117061594/doc4.xml","form_type":"4"}},{"id":4158976,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-17T23:05:40.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on December 13, 2016, were subject to both performance-based and time-based vesting requirements.  On November 15, 2017, the performance-based condition vesting was satisfied. The time-based vesting is on a quarterly pro-rata basis over a period of three (3) years from the date of grant."},{"field":"date","element":"transactionDate","label":"F2","text":"These restricted stock units (\"RSUs\") were granted on December 13, 2016 and the performance-based vesting requirement for these RSUs was satisfied on November 15, 2017 upon the Compensation Committee's certification of the successful acceptance of the New Drug Application by the FDA for Ciprofloxacin Dry Powder Inhalation (Cipro DPI)."}],"balance_after":253156,"source":{"system":"sec-edgar","filing":"0001209191-17-061594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117061594/doc4.xml","form_type":"4"}},{"id":4162814,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2017-11-15T23:02:50.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on November 17, 2017."}],"balance_after":0,"derivative":{"exercise_price":9.24,"exercise_date":"2010-11-18","expiration_date":"2017-11-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-060974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117060974/doc4.xml","form_type":"4"}},{"id":4162813,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-15T23:02:50.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":15910,"price":37.78,"value":601079.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on November 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $36.58 to $41.12. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":233156,"source":{"system":"sec-edgar","filing":"0001209191-17-060974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117060974/doc4.xml","form_type":"4"}},{"id":4162812,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-15T23:02:50.000Z","date":"2017-11-13","kind":"exercise","acquired":true,"shares":25000,"price":9.24,"value":231000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on November 17, 2017."}],"balance_after":249066,"source":{"system":"sec-edgar","filing":"0001209191-17-060974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117060974/doc4.xml","form_type":"4"}},{"id":4229937,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-08-18T23:04:49.000Z","date":"2017-08-16","kind":"sale","acquired":false,"shares":3177,"price":19.32,"value":61379.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.02  to $19.67.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":224066,"source":{"system":"sec-edgar","filing":"0001209191-17-049667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117049667/doc4.xml","form_type":"4"}},{"id":4287591,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2017-06-09T22:02:04.000Z","date":"2017-06-07","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017."}],"balance_after":0,"derivative":{"exercise_price":6.34,"exercise_date":"2013-06-10","expiration_date":"2017-06-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-038973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117038973/doc4.xml","form_type":"4"}},{"id":4287590,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-06-09T22:02:04.000Z","date":"2017-06-07","kind":"sale","acquired":false,"shares":101700,"price":19.24,"value":1956708.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.83 to $19.74. The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":227243,"source":{"system":"sec-edgar","filing":"0001209191-17-038973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117038973/doc4.xml","form_type":"4"}},{"id":4287589,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-06-09T22:02:04.000Z","date":"2017-06-07","kind":"exercise","acquired":true,"shares":150000,"price":6.34,"value":951000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017."}],"balance_after":328943,"source":{"system":"sec-edgar","filing":"0001209191-17-038973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117038973/doc4.xml","form_type":"4"}},{"id":4314315,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-05-19T00:49:19.000Z","date":"2017-05-16","kind":"sale","acquired":false,"shares":3146,"price":19.55,"value":61504.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":178943,"source":{"system":"sec-edgar","filing":"0001209191-17-033770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117033770/doc4.xml","form_type":"4"}},{"id":4440818,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-18T01:05:35.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":3237,"price":13.14,"value":42534.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":182089,"source":{"system":"sec-edgar","filing":"0001209191-17-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919117012407/doc4.xml","form_type":"4"}},{"id":4458004,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-11T01:11:41.000Z","date":"2017-02-10","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised."}],"balance_after":0,"derivative":{"exercise_price":4.65,"expiration_date":"2017-02-22","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-17-003648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317003648/doc4.xml","form_type":"4"}},{"id":4458003,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-11T01:11:41.000Z","date":"2017-02-10","kind":"exercise","acquired":true,"shares":45000,"price":4.65,"value":209250.0,"ownership":{"direct":true},"balance_after":185326,"source":{"system":"sec-edgar","filing":"0000899243-17-003648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317003648/doc4.xml","form_type":"4"}},{"id":4466983,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-03","kind":"exercise","acquired":false,"shares":8505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised."}],"balance_after":45000,"derivative":{"exercise_price":4.65,"expiration_date":"2017-02-22","underlying":"Common Stock","underlying_shares":8505},"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4466982,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-02","kind":"exercise","acquired":false,"shares":66495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised."}],"balance_after":53505,"derivative":{"exercise_price":4.65,"expiration_date":"2017-02-22","underlying":"Common Stock","underlying_shares":66495},"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4466981,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-03","kind":"sale","acquired":false,"shares":8505,"price":12.48,"value":106142.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reflects the weighted average sale price for open-market sales of Shares made by the Reporting Person on February 3, 2017. The actual prices for these transactions range from $12.45 to $12.51, inclusive."}],"balance_after":140326,"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4466980,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-03","kind":"exercise","acquired":true,"shares":8505,"price":4.65,"value":39548.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."}],"balance_after":148831,"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4466979,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-02","kind":"sale","acquired":false,"shares":66495,"price":12.38,"value":823208.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reflects the weighted average sale price for open-market sales of Shares made by the Reporting Person on February 2, 2017. The actual prices for these transactions range from $12.20 to $12.45, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":140326,"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4466978,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-06T22:20:33.000Z","date":"2017-02-02","kind":"exercise","acquired":true,"shares":66495,"price":4.65,"value":309201.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes."}],"balance_after":206821,"source":{"system":"sec-edgar","filing":"0000899243-17-002871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924317002871/doc4.xml","form_type":"4"}},{"id":4521141,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Stock Option","published_at":"2016-12-16T01:45:57.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":50000,"derivative":{"exercise_price":12.24,"expiration_date":"2024-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-16-155520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919116155520/doc4.xml","form_type":"4"}},{"id":4521140,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-16T01:45:57.000Z","date":"2016-12-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.  These RSUs vest over three years in equal quarterly installments based on continued service."}],"balance_after":140326,"source":{"system":"sec-edgar","filing":"0001209191-16-155520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919116155520/doc4.xml","form_type":"4"}},{"id":4549353,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":155416,"kind":"person","name":"Nicholson John","position":1,"cik":"0001420766","reported_name":"Nicholson John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-11-18T23:11:21.000Z","date":"2016-11-16","kind":"sale","acquired":false,"shares":1654,"price":13.96,"value":23089.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $13.71 to $14.14.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."}],"balance_after":120326,"source":{"system":"sec-edgar","filing":"0001209191-16-151304","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919116151304/doc4.xml","form_type":"4"}}]}